Perfluoroperhydrophenanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study.

Abstract

Fifty cases of retinal detachment with a giant retinal tear were managed using perfluoroperhydrophenanthrene (Vitreon) as an intraoperative and postoperative tool. The giant tear was less than 180 degrees in 76% of the eyes, greater than 180 degrees in 22%, and greater than 270 degrees in 2%. Proliferative vitreoretinopathy was present in 40%. Vitreon was used only intraoperatively in 84% of the eyes, and was left in 16% for up to 4 weeks. Intraoperative retinal reattachment was achieved in 98%. Retinal attachment was maintained in 88%, with a mean follow up of 8.6 months. Postoperative visual acuity was better than 20/400 in 52%. Postoperative complications included cataract in 23%, choroidal effusion in 2%, hypotony in 4%, and recurrent retinal detachment with proliferative vitreoretinopathy in 26%.

• Authors: C M Millsap, G A Peyman, N J Mehta, M D Greve, K J Lee, P E Ma, W A Dunlap
• Journal: Ophthalmic surgery (Ophthalmic Surg) Vol. 24 Issue 11 Pg. 759-63 (Nov 1993) ISSN: 0022-023X [Print] United States
• PMID: 8290216 (Publication Type: Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Fluorocarbons
• perfluorophenanthrene

Topics

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Child
• Eye Diseases (etiology)
• Female
• Fluorocarbons
• Humans
• Male
• Middle Aged
• Postoperative Complications
• Recurrence
• Retinal Detachment (surgery)
• Retinal Diseases (etiology)
• Retinal Perforations (surgery)
• Visual Acuity
• Vitreous Body